News
4 Apr 2026, 00:49
Hoskinson praises Midnight Ad as privacy tech drives institutional crypto adoption

Charles Hoskinson said Midnight makes blockchain safer and protects essential data while still complying with the rules, thereby increasing adoption among banks and institutional investors. Hoskinson said he loved the Matrix theme with Neo and Morpheus to show just how much users lack privacy online , and Midnight could be the solution that offers better privacy. Midnight uses privacy technology to keep user and business data safe People trust the blockchain because users can track transactions and verify that systems work properly without needing a central authority . However, this transparency comes with a serious privacy issue, as strangers, competitors, and criminals can access transaction records with malicious intent. The extent of data visibility creates new risks, as companies that pay suppliers in Bitcoin leave behind payment records competitors can use to learn about business relationships, costs, and operations. Similarly, criminals will always target users holding large amounts of crypto, using their wallet history to make malicious attempts. The Midnight ad showed how the system monitors every online activity, and blockchain isn’t any better since the public ledger records all financial transactions permanently. The advertisement also pointed to cases that stemmed from information leaks, such as crypto theft, exchange hacks, wallet hacks, and even physical kidnappings and robberies where criminals targeted crypto wallets. Midnight uses a technology called zero-knowledge proofs, which allow users to transact without sharing all their personal information or leaving an obvious trail. It also uses selective disclosure, where users and companies choose the information they want to share and what they want to keep private. As a result, a balance between transparency and privacy emerges, favoring banks and institutional investors who must protect customer data, business contracts, payment information, and internal financial records. While earlier blockchains focused on payments, then smart contracts, then scaling, Midnight takes it further by also focusing on privacy, data protection, and regulatory compliance. What’s more, private smart contracts will allow businesses to run contracts on the blockchain without sharing more details with the public. The levels of data access through selective disclosure on Midnight also allow regulators to see the information they need, while companies protect business secrets and users safeguard their personal data. Governments today want transparency and compliance in all business activities, but users and companies crave privacy, so Midnight is the middle child that allows controlled transparency and secrecy. Hoskinson says privacy technology helps more institutions use crypto Midnight launched its mainnet on March 30 after months of testing on its beta testnet, making it ready for real users, including companies, banks, and large investors seeking both privacy and compliance. Before the mainnet launch, Midnight ran the Midnight City Simulation to process zero-knowledge proofs at scale, and the results proved positive. Such preparation will help attract institutional investors accustomed to strict consumer protection and compliance laws. Midnight’s privacy technology also helps tokenize assets with sensitive information, and banks like Monument have already begun using the infrastructure to tokenize retail deposits. Hoskinson has always said that blockchain can only reach large institutions if they offer privacy infrastructure, because banks, governments, and financial organizations can’t operate fully transparent, decentralized systems. The simulation and launch demonstrate how well the network is ready for real-world use, and organizations that were hesitant to adopt blockchain due to privacy risks can now adopt Midnight in their operations. The Midnight ad proved that a lack of privacy is what’s blocking banks and institutions from adopting blockchain, but with the network’s new features, technology can be safe, usable, and compliant. If you're reading this, you’re already ahead. Stay there with our newsletter .
3 Apr 2026, 20:55
Strategic Expansion: Anthropic Acquires Biotech AI Startup Coefficient Bio in $400M Deal

BitcoinWorld Strategic Expansion: Anthropic Acquires Biotech AI Startup Coefficient Bio in $400M Deal In a significant move that underscores the accelerating convergence of artificial intelligence and biotechnology, Anthropic has reportedly acquired stealth startup Coefficient Bio in a $400 million stock transaction, according to multiple industry reports confirmed on April 3, 2026. This strategic acquisition represents Anthropic’s most substantial push into the healthcare and life sciences sector following its October announcement of Claude for Life Sciences, positioning the AI company at the forefront of computational drug discovery innovation. Anthropic’s Strategic Biotech Acquisition Details Multiple sources, including The Information and journalist Eric Newcomer, have confirmed the completion of Anthropic’s acquisition of Coefficient Bio. Sources close to the transaction verified to Bitcoin World that the deal has closed, though they declined to comment specifically on the financial terms. The $400 million stock deal valuation represents a substantial investment in early-stage biotech artificial intelligence capabilities. This transaction follows Anthropic’s established pattern of strategic expansion through targeted acquisitions that complement its core AI research and development efforts. The acquisition timing coincides with increasing investor interest in AI applications for healthcare. Furthermore, the deal structure as a stock transaction rather than cash suggests Anthropic’s confidence in its long-term valuation trajectory. Industry analysts note that stock-based acquisitions in the AI sector have become increasingly common as companies seek to preserve cash while leveraging their market valuations for strategic expansion. Coefficient Bio’s Foundational Expertise and Technology Coefficient Bio emerged from stealth mode with significant pedigree in computational drug discovery. Founders Samuel Stanton and Nathan C. Frey launched the startup just eight months before the acquisition, bringing extensive experience from their previous roles at Genentech’s Prescient Design division. Their background in applying machine learning to pharmaceutical research provided Coefficient Bio with immediate credibility in the competitive biotech AI landscape. The startup focused specifically on developing AI systems to accelerate drug discovery processes and enhance biological research efficiency. Their approach reportedly combined advanced machine learning algorithms with domain-specific biological knowledge, creating tools that could potentially reduce the time and cost associated with traditional pharmaceutical research methods. The approximately ten-person team developed proprietary methodologies for analyzing complex biological data, which attracted Anthropic’s attention as complementary to its existing Claude for Life Sciences platform. Industry Context and Competitive Landscape This acquisition occurs during a period of intense competition in the healthcare AI sector. Major technology companies, including Google, Microsoft, and NVIDIA, have all made significant investments in AI-powered healthcare solutions. Meanwhile, traditional pharmaceutical companies continue to partner with AI startups to enhance their research and development capabilities. Anthropic’s move positions it directly against established players like Recursion Pharmaceuticals, Insilico Medicine, and BenevolentAI, all of which have developed substantial AI platforms for drug discovery. The $400 million valuation for an eight-month-old startup reflects the premium market for proven AI talent in specialized domains. Additionally, the acquisition demonstrates how AI companies increasingly view vertical integration into specific industries as essential for long-term growth. By acquiring Coefficient Bio, Anthropic gains not only technology but also domain expertise that would typically require years to develop internally. Integration and Future Development Plans According to reports, Coefficient Bio’s entire team will join Anthropic’s health and life science division. This integration suggests Anthropic plans to maintain Coefficient Bio’s operational focus while leveraging Anthropic’s broader AI research infrastructure and computational resources. The combined teams will likely work to enhance Claude for Life Sciences with Coefficient Bio’s specialized drug discovery capabilities. Anthropic’s existing healthcare initiative, Claude for Life Sciences, aims to assist scientific researchers in making discoveries through natural language interactions with complex biological data. The integration of Coefficient Bio’s technology could significantly expand these capabilities into more specialized pharmaceutical research applications. Industry observers anticipate that the combined platform will offer researchers more sophisticated tools for target identification, compound screening, and clinical trial optimization. Market Implications and Regulatory Considerations The acquisition signals growing confidence in AI’s potential to transform pharmaceutical research despite ongoing regulatory uncertainty. The Food and Drug Administration continues to develop frameworks for evaluating AI-based medical technologies, creating both challenges and opportunities for companies operating in this space. Anthropic’s investment suggests confidence that regulatory pathways will become clearer as AI demonstrates tangible benefits in drug development. From a market perspective, this transaction may accelerate consolidation in the biotech AI sector. Smaller startups with promising technology but limited resources may increasingly seek partnerships or acquisitions by larger technology companies. Meanwhile, established pharmaceutical companies may feel increased pressure to either develop internal AI capabilities or form strategic alliances to remain competitive in an increasingly technology-driven research environment. Financial and Strategic Analysis The $400 million valuation represents a significant multiple for an early-stage startup, reflecting both the strategic importance of the acquisition and the competitive market for AI talent in healthcare. Stock-based transactions in the technology sector often indicate the acquiring company’s confidence in its future valuation, as dilution becomes less concerning when share prices are expected to appreciate substantially. Anthropic’s strategic focus appears to be shifting toward applied AI in specific vertical markets where its technology can demonstrate clear, measurable impact. The healthcare sector offers particularly compelling opportunities due to the complexity of biological data, the high costs of traditional research methods, and the potential for AI to accelerate life-saving discoveries. This acquisition follows a broader industry trend of AI companies moving beyond general-purpose models toward specialized applications with immediate commercial potential. Conclusion Anthropic’s acquisition of Coefficient Bio represents a strategic milestone in the convergence of artificial intelligence and biotechnology. The $400 million stock deal provides Anthropic with specialized expertise in computational drug discovery while accelerating its expansion into the healthcare sector. As the combined teams integrate Coefficient Bio’s technology with Anthropic’s Claude for Life Sciences platform, the industry will watch closely for innovations that could potentially transform pharmaceutical research methodologies. This acquisition signals both the growing maturity of AI applications in healthcare and the increasing competition among technology companies to establish leadership positions in specialized vertical markets with significant societal impact. FAQs Q1: What is the significance of Anthropic acquiring Coefficient Bio? The acquisition represents a major strategic expansion for Anthropic into healthcare AI, specifically drug discovery, combining its general AI capabilities with specialized biotech expertise in a rapidly growing market segment. Q2: How much did Anthropic pay for Coefficient Bio? Multiple reports indicate the acquisition was valued at approximately $400 million, structured as a stock transaction rather than a cash payment. Q3: What expertise does Coefficient Bio bring to Anthropic? Coefficient Bio’s founders and team have extensive experience in computational drug discovery from Genentech’s Prescient Design, specializing in AI applications for making biological research and pharmaceutical development more efficient. Q4: How will this acquisition affect Anthropic’s existing healthcare initiatives? The Coefficient Bio team will join Anthropic’s health and life science division, likely enhancing the existing Claude for Life Sciences platform with more specialized drug discovery capabilities and domain expertise. Q5: What does this acquisition indicate about the broader AI and biotech markets? The transaction signals increasing convergence between AI and biotechnology, growing investor confidence in healthcare AI applications, and potential acceleration of industry consolidation as larger technology companies acquire specialized startups. This post Strategic Expansion: Anthropic Acquires Biotech AI Startup Coefficient Bio in $400M Deal first appeared on BitcoinWorld .
3 Apr 2026, 20:50
Strategic Shakeup: OpenAI’s Brad Lightcap Transitions to Lead Crucial Special Projects in 2026 Leadership Reshuffle

BitcoinWorld Strategic Shakeup: OpenAI’s Brad Lightcap Transitions to Lead Crucial Special Projects in 2026 Leadership Reshuffle In a significant leadership reorganization, OpenAI announced multiple executive changes in April 2026 that reposition key personnel for the company’s next strategic phase, with Chief Operating Officer Brad Lightcap transitioning to lead special projects involving complex deals and investments. OpenAI Executive Changes Reshape Leadership Structure According to internal memos obtained by Bloomberg and confirmed to Bitcoin World, OpenAI is implementing substantial leadership transitions. The changes affect several senior executives simultaneously. CEO of AGI development Fidji Simo announced the personnel moves in a detailed communication to staff. These transitions come as OpenAI approaches nearly one billion global users while advancing frontier artificial intelligence research. The most notable change involves Brad Lightcap, OpenAI’s Chief Operating Officer. Consequently, Lightcap will now report directly to CEO Sam Altman. His new role focuses specifically on “special projects” that involve “complex deals and investments across the company.” This strategic move suggests OpenAI is prioritizing high-stakes partnerships and financial arrangements as it scales operations globally. Interim Leadership and Medical Leaves Announced Denise Dresser, the former Slack CEO who recently joined OpenAI as Chief Revenue Officer, will temporarily assume some of Lightcap’s previous COO responsibilities. This interim arrangement ensures operational continuity during the transition period. Meanwhile, Fidji Simo shared personal news in the same memo. She will take medical leave for several weeks to address a neuroimmune condition. “I have done everything possible to avoid it, but sadly my body isn’t cooperating,” Simo wrote in the memo. “The timing is maddening because we have such an exciting roadmap ahead that the team is executing on, and I hate to miss even a minute of it.” During her absence, OpenAI co-founder and president Greg Brockman will oversee product management responsibilities. This arrangement maintains leadership stability during Simo’s recovery period. Marketing Leadership Transition for Health Reasons Additionally, Kate Rouch, OpenAI’s Chief Marketing Officer, will step down from her role to focus on cancer recovery. The company memo indicated she will return to a “different, more narrowly scoped role when her health allows.” OpenAI plans to immediately begin searching for a new CMO to lead marketing initiatives. These health-related departures highlight the human element behind major technology companies while demonstrating organizational resilience through planned succession. OpenAI provided Bitcoin World with an official statement regarding the changes. “We have a strong leadership team focused on our biggest priorities: advancing frontier research, growing our global user base of nearly 1 billion users, and powering enterprise use cases,” the company stated. “We’re well-positioned to keep executing with continuity and momentum.” Strategic Implications of Leadership Reshuffle The executive changes occur during a critical growth phase for OpenAI. The company continues to expand its enterprise offerings while developing next-generation artificial intelligence systems. Lightcap’s move to special projects suggests several strategic priorities: Strategic Partnerships: Complex deals likely involve major technology integrations Investment Strategy: Directing capital toward promising AI research areas Enterprise Expansion: Securing large-scale corporate deployments International Growth: Navigating global regulatory environments Industry analysts note that special projects roles typically handle initiatives requiring executive-level attention but falling outside standard operational frameworks. These often include mergers and acquisitions, strategic investments, and high-value partnerships that could significantly impact company trajectory. Organizational Resilience and Succession Planning OpenAI’s ability to manage multiple simultaneous leadership transitions demonstrates mature organizational structure. The company has developed clear succession plans and interim management protocols. This resilience is particularly important for technology firms operating in fast-moving competitive environments. The appointments show OpenAI’s commitment to maintaining operational stability while pursuing strategic initiatives. Furthermore, the transparent handling of health-related leaves establishes positive corporate culture precedents. Technology companies increasingly recognize the importance of supporting executive health while maintaining business continuity. OpenAI’s approach balances compassion with professional responsibility through planned coverage arrangements. Industry Context and Competitive Landscape OpenAI’s leadership changes occur amid intense competition in artificial intelligence development. Major technology firms including Google, Microsoft, and Anthropic continue advancing their AI capabilities. Leadership stability and strategic positioning therefore become crucial competitive advantages. Special projects focusing on deals and investments could help OpenAI secure exclusive partnerships or technology advantages. The timing coincides with several industry developments. AI adoption continues accelerating across sectors while regulatory frameworks evolve globally. Consequently, Lightcap’s new role may involve navigating complex legal and business environments. His experience as COO provides valuable perspective for evaluating partnership opportunities and investment risks. Conclusion OpenAI’s April 2026 executive shuffle represents strategic repositioning for the company’s next growth phase. Brad Lightcap’s transition to special projects leadership highlights OpenAI’s focus on complex deals and investments. Simultaneously, interim leadership arrangements and health-related transitions demonstrate organizational resilience. These changes occur as OpenAI approaches one billion users while advancing frontier AI research. The company maintains strong leadership focus on research advancement, user growth, and enterprise applications throughout these transitions. FAQs Q1: What is Brad Lightcap’s new role at OpenAI? Brad Lightcap transitioned from Chief Operating Officer to lead special projects focusing on complex deals and investments across OpenAI, reporting directly to CEO Sam Altman. Q2: Who is temporarily assuming COO responsibilities at OpenAI? Denise Dresser, former Slack CEO and current OpenAI Chief Revenue Officer, will handle some COO duties during the transition period following Lightcap’s role change. Q3: Why is Fidji Simo taking medical leave? Fidji Simo, CEO of AGI development at OpenAI, is taking several weeks of medical leave to address a neuroimmune condition, with Greg Brockman managing product during her absence. Q4: What happened to OpenAI’s Chief Marketing Officer? Kate Rouch stepped down as CMO to focus on cancer recovery, with plans to return to a different, more narrowly scoped role when her health permits, while OpenAI searches for a new marketing head. Q5: How is OpenAI maintaining stability during these changes? OpenAI stated it has a strong leadership team focused on advancing research, growing its global user base, and powering enterprise use cases, with clear interim arrangements ensuring continuity and momentum. This post Strategic Shakeup: OpenAI’s Brad Lightcap Transitions to Lead Crucial Special Projects in 2026 Leadership Reshuffle first appeared on BitcoinWorld .
3 Apr 2026, 20:15
AI Data Centers Trigger Alarming Rush for Natural Gas Power Plants

BitcoinWorld AI Data Centers Trigger Alarming Rush for Natural Gas Power Plants In an unprecedented scramble for computing power, the world’s largest technology companies are now racing to secure a finite resource: natural gas. The explosive growth of artificial intelligence has created a voracious appetite for electricity, leading Microsoft, Google, and Meta to announce massive investments in natural gas-fired power generation specifically for their data centers. This strategic pivot toward fossil fuels marks a significant moment in the tech industry’s relationship with energy infrastructure and raises critical questions about sustainability, market stability, and long-term planning. The AI Power Crisis Driving Natural Gas Investments Artificial intelligence models, particularly large language models and generative AI systems, require staggering amounts of computational power. Training these models consumes exponentially more electricity than traditional cloud computing. Consequently, data center operators face a fundamental challenge: securing reliable, baseload power at scale. Renewable energy sources like wind and solar, while growing rapidly, often face intermittency issues that make them less suitable for the constant, high-demand operations of AI data centers. This technological reality has triggered what industry analysts describe as a “mad dash” for natural gas infrastructure. Natural gas power plants offer several advantages for tech companies. They provide dispatchable, 24/7 power generation. They can be built relatively quickly compared to nuclear facilities. Furthermore, they represent a known technology with established supply chains—at least until recently. Major Tech Players Forge Energy Partnerships The scale of recent announcements reveals the magnitude of this shift. On April 30, 2025, Microsoft confirmed a partnership with energy giants Chevron and Engine No. 1 to develop a natural gas power plant in West Texas. The project could eventually scale to produce 5 gigawatts of electricity—enough to power approximately 3.75 million homes. Simultaneously, Google disclosed its collaboration with Crusoe Energy Systems on a 933-megawatt natural gas plant in North Texas. Meta’s strategy involves significant expansion at its Hyperion data center complex in Louisiana. The company recently announced plans to add seven natural gas power plants to the site, bringing its total capacity to 7.46 gigawatts. To put this in perspective, that output exceeds the entire electricity consumption of South Dakota. These investments are concentrated in the southern United States, particularly Texas and Louisiana, regions sitting atop some of the world’s largest natural gas deposits. The Supply Chain Bottleneck: A Six-Year Wait for Turbines The sudden surge in demand has created severe supply chain constraints. According to analysis from Wood Mackenzie, prices for gas turbines—which constitute 20% to 30% of a power plant’s total cost—have skyrocketed. Prices are projected to be 195% higher by the end of 2025 compared to 2019 levels. More critically, lead times have stretched to unprecedented lengths. “Companies cannot place new orders for large gas turbines until 2028,” a Wood Mackenzie analyst noted. “The delivery timeline currently stands at six years from order to installation.” This bottleneck forces tech companies to make billion-dollar bets today on infrastructure that won’t be operational for most of the decade. It represents a massive gamble that AI’s power demands will continue their exponential growth trajectory. Behind-the-Meter Operations and Market Implications A key feature of these new projects is their “behind-the-meter” configuration. Instead of drawing power from the public electrical grid, these plants will connect directly to the companies’ own data centers. This approach allows tech firms to claim they are bringing new power generation online without straining existing grid infrastructure. However, energy economists point to a significant caveat. “They are simply shifting their demand from the electrical grid to the natural gas pipeline network,” explained Dr. Elena Rodriguez, an energy markets professor at Stanford University. “Natural gas generates about 40% of U.S. electricity. Large, concentrated demand from tech data centers could still influence regional gas prices, which in turn affect electricity prices for everyone.” The contracts between tech companies and energy suppliers remain confidential. The degree of price insulation these companies have secured is unknown. If their contracts are not firmly priced, they remain exposed to the volatility of the global natural gas market, which can be affected by geopolitical events, extreme weather, and production fluctuations. Geological Bounty Meets Production Reality The United States possesses enormous natural gas reserves. The U.S. Geological Survey estimates that the Wolfcamp Shale in the Permian Basin alone contains enough technically recoverable gas to supply the entire country for nearly ten months. This abundance has historically provided price stability and energy security. However, recent production trends introduce complexity. Growth in the three major U.S. shale gas regions—the Appalachia, Permian, and Haynesville basins—has slowed considerably. These regions account for three-quarters of the nation’s shale gas output. While reserves are vast, the rate at which they can be extracted economically is not infinite. The tech industry’s new demand represents a substantial incremental load on this system. Other industrial sectors are watching closely. Industries like petrochemical manufacturing, fertilizer production, and heavy manufacturing remain heavily dependent on natural gas as both a fuel and a feedstock. Unlike data centers, these industries cannot easily switch to renewable alternatives. A competition for resources could emerge, pitting digital infrastructure against foundational physical industries. The Weather Wild Card and Ethical Questions Extreme weather events present another layer of risk. The winter storm of 2021 in Texas demonstrated how cold snaps can freeze wellheads and cripple gas supply, leading to blackouts and price spikes. In a supply-constrained scenario, difficult prioritization decisions could arise. Should available gas flow to data centers running AI models or to residential heating systems? This scenario highlights the physical constraints of the digital economy. The AI revolution, often perceived as purely virtual, is fundamentally tethered to vast physical infrastructure—semiconductor fabs, fiber optic cables, and now, massive power generation facilities. The industry’s current trajectory represents a substantial bet on the continued availability and affordability of a finite fossil resource. Conclusion The race to build natural gas plants for AI data centers underscores a pivotal moment in technological and energy history. Companies like Microsoft, Google, and Meta are making long-term, capital-intensive bets to secure the power required for the next generation of artificial intelligence. While these investments may provide short-term solutions for powering AI growth, they introduce new dependencies on fossil fuel markets, create potential conflicts with other energy consumers, and present significant logistical and ethical challenges. The industry’s fear of missing out on AI dominance is now physically manifesting in the landscape of West Texas and beyond, reminding us that even the most advanced digital technologies remain rooted in the material world of turbines, pipelines, and gigawatts. FAQs Q1: Why are tech companies building natural gas plants instead of using more renewable energy? AI data centers require constant, reliable “baseload” power 24 hours a day. While tech companies are major investors in renewables, wind and solar power are intermittent. Natural gas plants can generate power on demand, making them a practical choice for meeting the massive, unwavering electricity demands of AI training and inference workloads. Q2: What does “behind-the-meter” mean in this context? A behind-the-meter power plant is directly connected to a specific facility—in this case, a data center—rather than feeding electricity into the public grid. This allows the tech company to be its own power provider, potentially avoiding grid congestion charges and increasing reliability. However, it still consumes fuel from the public natural gas pipeline network. Q3: How much power do these new natural gas plants produce? The announced projects are enormous. Microsoft’s Texas project could reach 5 gigawatts (GW). Meta’s Louisiana expansion will bring its site to 7.46 GW. For comparison, a single gigawatt can power roughly 750,000 average U.S. homes. These are utility-scale power generation facilities rivaling those built by traditional energy companies. Q4: Are there supply chain issues affecting these projects? Yes, a major bottleneck exists. The specialized turbines required for large natural gas power plants are in short supply. Lead times have stretched to six years, and new orders cannot be placed until 2028. This forces companies to plan far in advance and bet heavily on continued AI growth. Q5: Could this push for natural gas raise energy prices for consumers? Economists suggest it’s possible. Natural gas fuels about 40% of U.S. electricity generation. If tech companies secure large, long-term contracts or consume significant volumes, it could reduce supply available for other users or electricity generation, potentially applying upward pressure on market prices, especially during periods of high demand or supply constraint. This post AI Data Centers Trigger Alarming Rush for Natural Gas Power Plants first appeared on BitcoinWorld .
3 Apr 2026, 19:20
Avalanche price prediction 2026-2032: Time to buy AVAX?

Key takeaways: Our Avalanche price prediction anticipates a high of $22.10 in 2026. In 2028, the price range is expected to be between $29.97 and $35.18, with an average price of $30.82. In 2031, the range is likely to be between $95.99 and $109.93, with an average price of $99.25. AVAX experienced significant price fluctuations this year. This record came amid a drop in the crypto market valuation and regional tensions in the Middle East. While the Avalanche network has been making strides, the AVAX price has left investors particularly questioning its trajectory. Will AVAX go up? Is AVAX a good investment? Let’s explore these and more in our Cryptopolitan price prediction from 2026 to 2032. Overview Cryptocurrency Avalanche Symbol AVAX Current price $9.00 Market cap $3.88B Trading volume $191.42M Circulating supply 431.77M All-time high $146.22 on Nov 21, 2021 All-time low $2.79 on Dec 31, 2020 24-hour high $9.13 24-hour low $8.65 Avalanche price prediction: Technical analysis Metric Value Volatility (30-day variation) 4.48% (Medium) 50-day SMA $9.34 200-day SMA $14.43 Sentiment Bearish Green days 16/30 (53%) Fear and Greed Index 9 (Extreme Greed) Avalanche price analysis On April 3, the AVAX price rose 4.20% over 24 hours and fell 5.60% over 30 days. Its trading volume dropped (33.62%) to $191M in 24 hours, showing less trading interest. AVAX/USD 1-day chart analysis AVAXUSD chart by TradingView This month, AVAX remained bearish, falling below $10 and recently below $9. The coin now has a bearish Relative Strength Index (RSI). The William Alligator trendlines indicate waning volatility, while the MACD histograms show negative momentum. AVAX has support at $8.58. AVAX/USD 4-hour chart analysis AVAXUSD chart by TradingView Over the short term, AVAX remained volatile, ranging between $8 and $10. Its momentum rose in the last 24 hours as it bounced off support levels. Its relative strength index (53.83) shows it is in neutral territory. Avalanche technical indicators: Levels and action Daily simple moving average (SMA) Period Value ($) Action SMA 3 10.90 SELL SMA 5 9.94 SELL SMA 10 9.22 SELL SMA 21 9.39 SELL SMA 50 9.34 SELL SMA 100 11.02 SELL SMA 200 14.43 SELL Daily exponential moving average (EMA) Period Value ($) Action EMA 3 9.28 SELL EMA 5 9.59 SELL EMA 10 10.44 SELL EMA 21 11.46 SELL EMA 50 12.97 SELL EMA 100 15.48 SELL EMA 200 18.54 SELL What to expect from the AVAX price analysis next? Technical analysis of Avalanche price movements suggests it is bearish. The charts show that its momentum is rising, suggesting it will drop over the short term. Why is Avalanche down? AVAX is caught in a market-wide downdraft, with its technical breakdown amplifying the sell-off. While positive developments like the ETF filing provide long-term optionality, they are not offsetting near-term macro fears. Will AVAX reach $50? According to the Cryptopolitan price prediction, AVAX is expected to cross $50 in 2029, reaching a maximum price of $52.03. Will AVAX reach $100? According to the Cryptopolitan price prediction, AVAX will reach $100 in 2031, with a maximum price of $109.93. Can Avalanche reach $1,000? It remains highly unlikely that AVAX will reach $1,000 before 2031. At that market capitalization, it could be more valuable than Ethereum. Can Avalanche reach $10,000? It remains highly unlikely that AVAX will reach $10,000 before 2031. How much will Avalanche be worth in 2026? As 2026 unfolds, we anticipate it will trade between $7.00 and $22.10, with an average price of $18.89. Does Avalanche have a good long-term future? According to Cryptopolitan price predictions, AVAX will trade higher in the coming years. However, factors like market crashes or negative regulations could invalidate this bullish theory. Is Avalanche a good crypto to buy? Chart analysis suggests that Avalanche is recovering and currently gearing up for a closer move to $20 despite the overall bearish momentum. AVAX price prediction April 2026 For April, AVAX will trade between $9.10 and $13.10, with an average price of $10.01. Month Potential low ($) Potential average ($) Potential high ($) April 7.59 10.01 13.10 Avalanche price prediction 2026 As 2026 unfolds, its future price movements suggest it will trade between $7.00 and $22.10, with an average price of $12.89. Year Potential low ($) Potential average ($) Potential high ($) 2026 7.00 12.89 22.10 Avalanche price prediction 2027-2032 Year Potential low ($) Potential average ($) Potential high ($) 2027 20.4900 22.2100 24.7600 2028 29.9700 30.8200 35.1800 2029 43.5500 44.7900 52.0300 2030 62.8400 65.07 74.7400 2031 95.9900 99.25 109.9300 2032 141.6400 145.6100 164.6400 AVAX price prediction 2027 Avalanche price prediction climbs even higher into 2027. According to the projection, the price will range from $20.49 to $24.76, with an average trading price of $22.21. Avalanche crypto price prediction 2028 Our Avalanche price prediction indicates further price acceleration. It will trade between $29.97 and $35.18, with an average of $30.82. Avalanche price prediction 2029 According to the AVAX coin price prediction for 2029, the price of AVAX will range from a minimum price of $43.55 to a maximum price of $52.03. The average price will be $44.79. Avalanche AVAX price prediction 2030 According to the Avalanche price prediction for 2030, we anticipate a range of $62.84 to $74.74, with an average price of $65.07. Avalanche price prediction 2031 The Avalanche price forecast ranges from $95.99 to $109.93, with an average closing price of $99.25. Avalanche price prediction 2032 The Avalanche AVAX price forecast indicates it will trade between $141.64 and $164.64, with an average trading price of $145.61. Avalanche price prediction 2026 – 2032 Avalanche market price prediction: Analysts’ AVAX price forecast Platform 2026 2027 2028 Coincodex $7.56 $7.54 $7.40 Gate.com $9.00 $9.03 $11.94 Cryptopolitan Avalanche price prediction Our predictions indicate that Avalanche will achieve a high level of $22.10 in 2026. In 2027, it will range between $20.49 and $24.76, with an average price of $22.10. In 2031, the range will be between $95.99 and $109.93, with an average of $99.25. Note that the predictions are not investment advice. Seek independent consultation or do your own research. Avalanche historic price sentiment Avalanche price history. Image source CoinGecko In July 2020, Avalanche completed its public sale, raising $42 million in under 4.5 hours. The tokens were distributed after the mainnet launch in September. On Dec 31, 2020, it fell to an all-time low of $2.79. In September 2021, the Ava Labs Foundation received a $230 million investment from Polychain and Three Arrows Capital Group by purchasing AVAX. In November 2021, following an agreement with Deloitte to improve US disaster relief funding, AVAX moved to the top 10 cryptocurrencies by market capitalization. At that time, AVAX reached an all-time high of $146.22. In Aug 2022, a whistleblower, ‘crypto leaks’, published a report accusing Ava Labs of secret deals with a law firm to destabilize its competitors. Ava Labs CEO Emin Gün Sirer denied any involvement in a shady deal with the Roche Freedman law firm. In 2023, AVAX maintained a bullish trend from January to May, after which bears took control of the market. It resumed the positive momentum in October, rising to $49.96. In 2024, it crossed the $60 mark in March. The rise coincided with a record high in AVAX inscriptions, with over 100 million ASC-20 minted since their introduction in June 2023. The uptrend reversed in April 2024; by July, it had fallen to $24.40. In August, it was at $21, and in September and October, it was at $27. It turned bullish in November 2024, rising from as low as $23 to $55 in December. It corrected later and traded at $42 into 2025. The drop continued into January; by June, it had fallen below $20. In July, it traded at $18, and in September, at $23. In October, it rose above $30. It then reversed, and by December, had dropped to $14. It maintained the price into January 2026. It later turned bearish, and in March and April, it reached $9.
3 Apr 2026, 19:00
U.S. MATCH Act would cut chip equipment sales and servicing to key Chinese firms

A group of American lawmakers from both parties has put forward a new bill that would sharply limit China’s ability to get hold of the equipment it needs to make advanced computer chips. The legislation, called the MATCH Act, was introduced late Thursday. It aims to keep the United States ahead in the artificial intelligence race by stopping Chinese companies from buying chip-making machines they cannot produce on their own. Much of the attention falls on ASML, a Dutch company that is the only maker of the most advanced chip production equipment in the world. Past restrictions on what China could import were pushed through by the White House under both the Trump and Biden administrations. This time, the push is coming directly from Congress. The lawmakers behind the bill include Congressman Michael Baumgartner and John Moolenaar, who chairs the House Select Committee on China. According to Baumgartner’s office , the Multilateral Alignment of Technology Controls on Hardware Act, MATCH for short, is designed to close what it calls “critical gaps” in the rules that already exist. “The MATCH Act will close loopholes, create a level playing field for U.S. and allied toolmakers, and ensure the next decade of growth in chip manufacturing… happens in the United States and allied countries, not China,” the report from his office states. Bill targets older machines and named Chinese firms The bill takes direct aim at a specific type of chip-making machine called immersion DUV lithography. China buys most of these from ASML and, to a lesser extent, from its smaller Japanese competitor, Nikon. Rules already bar ASML from selling its newest and most powerful EUV machines to China. But the MATCH Act would go further. It would ban the sale and even the maintenance of older DUV machines to major Chinese chip companies. The bill clearly designates SMIC, Hua Hong, Huawei, CXMT, YMTC, and associated companies as targets. If the legislation is approved, these businesses would receive exports, servicing, and technical assistance in the same manner that the United States presently treats businesses on its Entity List. This would essentially compel ASML to violate current agreements and give up a significant portion of its business. With 33% of ASML’s total revenue in 2025, China was the company’s largest market. This year, that percentage is already predicted to drop to about 20%. One of the bill’s central goals is to make sure that American allies play by the same rules as U.S. companies. The proposal gives allied countries 150 days to show they are tightening their own controls. If they fall short, the Department of Commerce would be directed to put the restrictions in place on its own. The bill also widens U.S. authority over goods made in other countries if they include American software, technology, or parts. Senator Pete Ricketts spoke plainly about what the bill is trying to fix. “For too long, our export controls have been a patchwork of entity-based restrictions that Beijing easily bypasses using front companies,” he said. “The MATCH Act strengthens our controls and creates a level playing field for U.S. companies.” The Dutch government offered a careful response to the bill. A spokesperson from the Netherlands’ foreign ministry said it was “not our place to comment on draft legislation proposed by lawmakers from other countries.” ASML said nothing publicly on Friday. Rare earth squeeze looms as China’s likely countermove China could attempt to tighten its hold on rare earth elements, another piece of the technology puzzle, in response to Washington’s efforts to tighten regulations on chip equipment. A top Chinese delegation had recently visited research facilities and manufacturers to advocate for closer cooperation between the mining, production, and commercial usage of these commodities, according to state-affiliated industry sources. China could carefully control its rare earth business, as evidenced by the visit, which emphasized the need to ensure supply and maintain stable prices. The concern for Western technology companies is not just about raw materials. China already leads in the processing of rare earths and in manufacturing products like electric vehicle motors and industrial robots that depend on them. If you're reading this, you’re already ahead. Stay there with our newsletter .










































